Placental microRNAs: Responders to environmental chemicals and mediators of pathophysiology of the human placenta
- PMID: 32913718
- PMCID: PMC7472806
- DOI: 10.1016/j.toxrep.2020.08.002
Placental microRNAs: Responders to environmental chemicals and mediators of pathophysiology of the human placenta
Abstract
MicroRNAs (miRNAs) are epigenetic modifiers that play an important role in the regulation of the expression of genes across the genome. miRNAs are expressed in the placenta as well as other organs, and are involved in several biological processes including the regulation of trophoblast differentiation, migration, invasion, proliferation, apoptosis, angiogenesis and cellular metabolism. Related to their role in disease process, miRNAs have been shown to be differentially expressed between normal placentas and placentas obtained from women with pregnancy/health complications such as preeclampsia, gestational diabetes mellitus, and obesity. This dysregulation indicates that miRNAs in the placenta likely play important roles in the pathogenesis of diseases during pregnancy. Furthermore, miRNAs in the placenta are susceptible to altered expression in relation to exposure to environmental toxicants. With relevance to the placenta, the dysregulation of miRNAs in both placenta and blood has been associated with maternal exposures to several toxicants. In this review, we provide a summary of miRNAs that have been assessed in the context of human pregnancy-related diseases and in relation to exposure to environmental toxicants in the placenta. Where data are available, miRNAs are discussed in their context as biomarkers of exposure and/or disease, with comparisons made across-tissue types, and conservation across studies detailed.
Keywords: Epigenetic; Maternal; Placenta; Prenatal; microRNA.
© 2020 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Human placental microRNAs and preeclampsia.Biol Reprod. 2013 May 23;88(5):130. doi: 10.1095/biolreprod.113.107805. Print 2013 May. Biol Reprod. 2013. PMID: 23575145 Free PMC article. Review.
-
MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1.Am J Obstet Gynecol. 2018 Feb;218(2):249.e1-249.e12. doi: 10.1016/j.ajog.2017.11.568. Epub 2017 Nov 16. Am J Obstet Gynecol. 2018. PMID: 29155142
-
MicroRNAs in Human Placental Development and Pregnancy Complications.Int J Mol Sci. 2013 Mar 8;14(3):5519-44. doi: 10.3390/ijms14035519. Int J Mol Sci. 2013. PMID: 23528856 Free PMC article.
-
Dysregulation of Placental miRNA in Maternal Obesity Is Associated With Pre- and Postnatal Growth.J Clin Endocrinol Metab. 2017 Jul 1;102(7):2584-2594. doi: 10.1210/jc.2017-00089. J Clin Endocrinol Metab. 2017. PMID: 28368446
-
Placental miRNAs in feto-maternal communication mediated by extracellular vesicles.Placenta. 2020 Dec;102:27-33. doi: 10.1016/j.placenta.2020.07.001. Epub 2020 Jul 11. Placenta. 2020. PMID: 33218575 Review.
Cited by
-
The Ratio of Cysteine-Rich Angiogenic Inducer 61 to MicroRNA -155 Expression as a Preeclampsia Diagnostic Marker and Predictor of Its Severity.Rep Biochem Mol Biol. 2023 Jul;12(2):332-339. doi: 10.61186/rbmb.12.2.332. Rep Biochem Mol Biol. 2023. PMID: 38317812 Free PMC article.
-
Characterization of Maternal Circulating MicroRNAs in Obese Pregnancies and Gestational Diabetes Mellitus.Antioxidants (Basel). 2023 Feb 17;12(2):515. doi: 10.3390/antiox12020515. Antioxidants (Basel). 2023. PMID: 36830073 Free PMC article.
-
Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy.Mol Cell Endocrinol. 2023 Nov 1;577:112031. doi: 10.1016/j.mce.2023.112031. Epub 2023 Jul 26. Mol Cell Endocrinol. 2023. PMID: 37506868 Free PMC article. No abstract available.
-
Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia.Front Immunol. 2024 Mar 19;15:1385950. doi: 10.3389/fimmu.2024.1385950. eCollection 2024. Front Immunol. 2024. PMID: 38566996 Free PMC article. Review.
-
Gestational Exposure to Endocrine-Disrupting Chemicals of Emerging Concern and the Risk of Developing Gestational Diabetes Mellitus: A Comprehensive Investigation of Sex-Specific and Trimester-Specific Associations.Environ Health (Wash). 2024 Nov 22;3(3):271-281. doi: 10.1021/envhealth.4c00202. eCollection 2025 Mar 21. Environ Health (Wash). 2024. PMID: 40144318 Free PMC article.
References
-
- Gude N.M. Growth and function of the normal human placenta. Thromb. Res. 2004;114(5–6):397–407. - PubMed
-
- Amankwah K.S., Kaufmann R.C. Ultrastructure of human placenta: effects of maternal drinking. Gynecol. Obstet. Invest. 1984;18(6):311–316. - PubMed
-
- Kotlabova K., Doucha J., Hromadnikova I. Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J. Reprod. Immunol. 2011;89(2):185–191. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources